X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (9225) 9225
Publication (1714) 1714
Book Review (1437) 1437
Book Chapter (149) 149
Conference Proceeding (99) 99
Dissertation (18) 18
Reference (5) 5
Data Set (2) 2
Government Document (1) 1
Magazine Article (1) 1
Streaming Video (1) 1
Web Resource (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (7440) 7440
animals (5991) 5991
male (3730) 3730
neurosciences (3209) 3209
humans (3125) 3125
rats (2798) 2798
pharmacology & pharmacy (2656) 2656
receptor, cannabinoid, cb1 - metabolism (2654) 2654
mice (2410) 2410
endocannabinoids (2215) 2215
receptor, cannabinoid, cb1 - antagonists & inhibitors (1781) 1781
endocannabinoid system (1674) 1674
pyrazoles - pharmacology (1669) 1669
piperidines - pharmacology (1609) 1609
cb1 receptor (1496) 1496
anandamide (1445) 1445
cannabinoids (1392) 1392
brain (1321) 1321
female (1313) 1313
cb1 (1302) 1302
receptor, cannabinoid, cb1 - agonists (1198) 1198
dose-response relationship, drug (1109) 1109
cb1 receptors (1075) 1075
receptor, cannabinoid, cb1 - genetics (1062) 1062
cannabinoid (1061) 1061
rats, sprague-dawley (1058) 1058
cannabinoid cb1 receptors (980) 980
article (962) 962
rats, wistar (930) 930
biochemistry & molecular biology (922) 922
lipids (918) 918
cannabinoids - pharmacology (914) 914
cannabinoid receptor (904) 904
cannabinoid receptors (894) 894
arachidonic acids - pharmacology (879) 879
receptor, cannabinoid, cb1 - physiology (872) 872
psychiatry (854) 854
mice, inbred c57bl (819) 819
activation (811) 811
acid amide hydrolase (775) 775
neurons (743) 743
morpholines - pharmacology (735) 735
receptors (728) 728
receptor, cannabinoid, cb2 - metabolism (727) 727
nervous system (726) 726
analysis (718) 718
disease models, animal (698) 698
naphthalenes - pharmacology (687) 687
mice, knockout (666) 666
rat-brain (665) 665
cannabinoid receptor modulators - metabolism (657) 657
rimonabant (653) 653
rodents (644) 644
obesity (627) 627
receptor (619) 619
pharmacology (618) 618
expression (613) 613
rat (613) 613
ligands (601) 601
inhibition (586) 586
endogenous cannabinoids (583) 583
dronabinol - pharmacology (576) 576
marijuana (572) 572
endocannabinoid (571) 571
endocannabinoids - metabolism (564) 564
physiological aspects (558) 558
brain - metabolism (557) 557
cannabinoid cb1 receptor (536) 536
arachidonic acids - metabolism (495) 495
chemistry, medicinal (490) 490
neurology (486) 486
cell biology (484) 484
signal transduction (484) 484
food-intake (478) 478
endocrinology & metabolism (468) 468
adult (464) 464
receptor, cannabinoid, cb1 - drug effects (457) 457
clinical neurology (451) 451
research (447) 447
cannabis (446) 446
pain (435) 435
hippocampus (434) 434
in-vivo (429) 429
benzoxazines - pharmacology (420) 420
time factors (410) 410
brain - drug effects (409) 409
behavioral sciences (405) 405
antagonist (403) 403
neurons - metabolism (401) 401
system (399) 399
fatty acids (398) 398
delta-tetrahydrocannabinol (397) 397
cannabinoid receptor modulators - physiology (394) 394
cells, cultured (394) 394
behavior, animal - drug effects (393) 393
receptor, cannabinoid, cb2 - agonists (392) 392
cb1 cannabinoid receptor (391) 391
neurons - drug effects (390) 390
physiology (387) 387
anxiety (381) 381
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (9173) 9173
French (44) 44
Chinese (33) 33
German (23) 23
Spanish (19) 19
Japanese (17) 17
Russian (10) 10
Polish (8) 8
Czech (4) 4
Korean (4) 4
Dutch (3) 3
Italian (3) 3
Hungarian (2) 2
Portuguese (2) 2
Danish (1) 1
Hebrew (1) 1
Norwegian (1) 1
Persian (1) 1
Ukrainian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Neuropsychopharmacology, ISSN 0893-133X, 01/2012, Volume 37, Issue 2, pp. 478 - 486
The midbrain dorsal periaqueductal gray (dPAG) has an important role in orchestrating anxiety-and panic-related responses. Given the cellular and behavioral... 
vanilloid | anxiety | anandamide | cannabinoid | periaqueductal gray | panic | PSYCHIATRY | ENDOCANNABINOID SYSTEM | GREY-MATTER | NEUROSCIENCES | PREFRONTAL CORTEX | DORSOLATERAL PERIAQUEDUCTAL GRAY | ACID AMIDE HYDROLASE | LONG-TERM DEPRESSION | PHARMACOLOGY & PHARMACY | CENTRAL-NERVOUS-SYSTEM | BRAIN | Rats, Wistar | Capsaicin - pharmacology | Cinnamates - administration & dosage | Microinjections - methods | Periaqueductal Gray - drug effects | Male | Piperidines - antagonists & inhibitors | Receptor, Cannabinoid, CB1 - physiology | Capsaicin - administration & dosage | TRPV Cation Channels - metabolism | Drug Interactions | Receptor, Cannabinoid, CB1 - agonists | Piperidines - pharmacology | Arachidonic Acids - administration & dosage | TRPV Cation Channels - antagonists & inhibitors | Electric Stimulation - methods | Pyrazoles - pharmacology | Panic - drug effects | Piperidines - administration & dosage | TRPV Cation Channels - physiology | Rats | Capsaicin - analogs & derivatives | Cinnamates - pharmacology | Arachidonic Acids - pharmacology | Receptor, Cannabinoid, CB1 - metabolism | Panic - physiology | Pyrazoles - administration & dosage | Animals | Anilides - administration & dosage | Anilides - pharmacology | Periaqueductal Gray - physiology | Receptor, Cannabinoid, CB1 - antagonists & inhibitors | Pyrazoles - antagonists & inhibitors | Index Medicus | animal models | psychopharmacology | mood | stress disorders | cannabinoids | Original
Journal Article
Neuropharmacology, ISSN 0028-3908, 10/2012, Volume 63, Issue 5, pp. 905 - 915
Mu-opioid and CB1-cannabinoid agonists produce analgesia; however, adverse effects limit use of drugs in both classes. Additive or synergistic effects... 
Analgesia | Morphine | Marijuana | G-protein | Adenylyl cyclase | CB1 receptors | AGONIST MORPHINE | ACTIVATION | PROTEIN-KINASE | CB1 CANNABINOID RECEPTOR | SYNERGISTIC INTERACTIONS | NEUROSCIENCES | INHIBITION | KAPPA | FULL AGONIST | ADENYLYL-CYCLASE | PHARMACOLOGY & PHARMACY | RAT-BRAIN | Pyrazoles - therapeutic use | Receptor, Cannabinoid, CB2 - agonists | Humans | Analgesics, Opioid - pharmacology | Receptors, Opioid, mu - agonists | Piperidines - pharmacology | Cannabinoid Receptor Agonists - therapeutic use | Recombinant Proteins - antagonists & inhibitors | Piperidines - metabolism | Receptors, Opioid, mu - metabolism | Morpholines - metabolism | Analgesics, Non-Narcotic - metabolism | Drug Inverse Agonism | Mice | Analgesics, Opioid - metabolism | Kinetics | Receptor, Cannabinoid, CB1 - antagonists & inhibitors | Analgesics, Opioid - antagonists & inhibitors | Cannabinoid Receptor Agonists - metabolism | Cricetulus | Analgesics, Non-Narcotic - pharmacology | Cannabinoid Receptor Agonists - pharmacology | Receptor, Cannabinoid, CB2 - genetics | Analgesics, Opioid - adverse effects | Narcotic Antagonists - metabolism | Receptor, Cannabinoid, CB1 - agonists | Analgesics, Non-Narcotic - adverse effects | Cannabinoid Receptor Agonists - adverse effects | Morpholines - adverse effects | CHO Cells | Pyrazoles - adverse effects | Pyrazoles - pharmacology | Binding, Competitive | Recombinant Proteins - metabolism | Cricetinae | Morpholines - pharmacology | Narcotic Antagonists - adverse effects | Recombinant Proteins - agonists | Analgesics, Non-Narcotic - therapeutic use | Pyrazoles - metabolism | Mice, Inbred Strains | Receptors, Opioid, mu - antagonists & inhibitors | Receptor, Cannabinoid, CB1 - metabolism | Receptor, Cannabinoid, CB2 - metabolism | Animals | Narcotic Antagonists - therapeutic use | Piperidines - therapeutic use | Narcotic Antagonists - pharmacology | Piperidines - adverse effects | Receptors, Opioid, mu - genetics | Index Medicus | Drugs | Pain perception | Opioid receptors | Cyclic AMP | Opioid receptors (type mu) | Antagonists | Cannabinoid CB1 receptors | Guanine nucleotide-binding protein | Antagonism | Cell activation | Side effects | Inverse agonists | CB1 Receptors | Adenylyl Cyclase
Journal Article
Journal Article
PLoS ONE, ISSN 1932-6203, 12/2016, Volume 11, Issue 12, pp. e0167240 - e0167240
Tamoxifen (Tam) is a selective estrogen receptor (ER) modulator (SERM) that is an essential drug to treat ER-positive breast cancer. Aside from known actions... 
SIGNAL-TRANSDUCTION | IN-VITRO | ALLOSTERIC MODULATORS | HUMAN-BREAST-CANCER | MULTIDISCIPLINARY SCIENCES | INVERSE AGONIST | CELL-GROWTH | RAT-BRAIN | ADENYLATE-CYCLASE | ESTROGEN-RECEPTOR | CB1 RECEPTOR | Cannabinoid Receptor Agonists - metabolism | Cricetulus | Receptor, Cannabinoid, CB2 - agonists | Humans | Receptor, Cannabinoid, CB2 - antagonists & inhibitors | Cannabinoid Receptor Agonists - pharmacology | Isomerism | Breast Neoplasms - metabolism | Indoles - metabolism | Cyclohexanols - metabolism | Receptor, Cannabinoid, CB1 - agonists | Colforsin - metabolism | Tamoxifen - chemistry | Cannabinoid Receptor Antagonists - pharmacology | Female | Indoles - pharmacology | Cyclohexanols - pharmacology | Cyclic AMP - metabolism | CHO Cells | Binding, Competitive | Tamoxifen - metabolism | Cricetinae | Colforsin - pharmacology | Selective Estrogen Receptor Modulators - chemistry | Adenylyl Cyclases - metabolism | Breast Neoplasms - drug therapy | Selective Estrogen Receptor Modulators - metabolism | Receptor, Cannabinoid, CB1 - metabolism | Receptor, Cannabinoid, CB2 - metabolism | Guanosine 5'-O-(3-Thiotriphosphate) - metabolism | Animals | Cannabinoid Receptor Antagonists - metabolism | Tamoxifen - pharmacology | Tamoxifen - analogs & derivatives | Receptor, Cannabinoid, CB1 - antagonists & inhibitors | Selective Estrogen Receptor Modulators - pharmacology | GTP-Binding Proteins - metabolism | Cell receptors | Patient outcomes | Drug metabolism | Development and progression | Genetic aspects | Breast cancer | Tamoxifen | Drug therapy | Health aspects | Cytochrome | Drugs | Estrogens | Estrogen receptors | Drug development | Isomers | Proteins | Adenylate cyclase | Osteoporosis | Receptors | Toxicology | Cell growth | Metabolites | Cannabinoid CB2 receptors | Cannabinoid receptors | Medical treatment | Cytochrome P450 | Pharmacology | Cannabinoid CB1 receptors | FDA approval | Medicine | Studies | Inverse agonists | Affinity | Selective estrogen receptor modulators | Cancer | Index Medicus
Journal Article
Journal Article
Pflügers Archiv - European Journal of Physiology, ISSN 0031-6768, 2/2018, Volume 470, Issue 2, pp. 395 - 411
The dorsal hippocampus (DH) is involved in the modulation of the cardiac baroreflex function. There is a wide expression of the NMDA and AMPA/Kainate receptors... 
Neurosciences | Human Physiology | GABA A receptor | Cell Biology | Receptors | Biomedicine | Autonomic nervous system | AMPA/Kainate receptors | Baroreflex | Cannabinoid receptor | Molecular Medicine | NMDA receptor | Endocannabinoids | receptor | GABA | CB1 CANNABINOID RECEPTORS | CARDIOVASCULAR-RESPONSES | PHYSIOLOGY | ACUTE RESTRAINT STRESS | UNANESTHETIZED RATS | BARORECEPTOR REFLEX | HYPOTHALAMIC PARAVENTRICULAR NUCLEUS | BED NUCLEUS | STRIA TERMINALIS | GABA(A) receptor | ELECTRICAL-STIMULATION | NITRIC-OXIDE | Receptors, Glutamate - metabolism | Rats, Wistar | Heart - physiology | Rats | Male | Excitatory Amino Acid Antagonists - pharmacology | Hippocampus - drug effects | Synaptic Transmission | GABA Antagonists - pharmacology | Receptors, Cannabinoid - metabolism | Hippocampus - metabolism | Animals | Receptors, GABA - metabolism | Cannabinoid Receptor Antagonists - pharmacology | Hippocampus - physiology | Medical colleges | Brain | Glutamate | Heart | Kainic acid receptors | Baroreceptors | Interneurons | γ-Aminobutyric acid A receptors | Glutamic acid receptors (ionotropic) | N-Methyl-D-aspartic acid receptors | Glutamic acid receptors | Cannabinoid CB1 receptors | Injection | γ-Aminobutyric acid | Tachycardia | α-Amino-3-hydroxy-5-methyl-4-isoxazole propionic acid | Vasoactive agents | Rodents | Blood pressure | Glutamatergic transmission | Heart diseases | Hippocampus | Reflexes | Bicuculline | Index Medicus
Journal Article
Journal of Neuroscience, ISSN 0270-6474, 04/2007, Volume 27, Issue 14, pp. 3663 - 3676
Journal Article
Neuropharmacology, ISSN 0028-3908, 08/2013, Volume 71, Issue 100, pp. 255 - 263
The G protein-coupled receptor 55 (GPR55) is a novel cannabinoid (CB) receptor, whose role in the gastrointestinal (GI) tract remains unknown. Here we studied... 
Cannabidiol | Gastrointestinal motility | Colon | Cannabinoid | GPR55 | ENDOCANNABINOID SYSTEM | MOUSE COLON | FUNCTIONAL GASTROINTESTINAL DISORDERS | NEUROSCIENCES | PATHOPHYSIOLOGY | IN-VITRO | CANNABINOID RECEPTOR | CB1 | LIGANDS | PHARMACOLOGY | PHARMACOLOGY & PHARMACY | IRRITABLE-BOWEL-SYNDROME | Colon - cytology | Tissue Banks | Receptor, Cannabinoid, CB2 - agonists | Humans | Colon - drug effects | Gastrointestinal Motility - drug effects | Cannabidiol - analogs & derivatives | Colon - innervation | Colonic Diseases, Functional - drug therapy | Male | Neurons - cytology | Myenteric Plexus - metabolism | Receptor, Cannabinoid, CB2 - antagonists & inhibitors | Molecular Targeted Therapy | Receptor, Cannabinoid, CB2 - genetics | Receptors, Cannabinoid - metabolism | Muscle, Smooth - drug effects | Receptor, Cannabinoid, CB1 - agonists | Cannabinoid Receptor Antagonists - pharmacology | Cannabidiol - therapeutic use | Neurons - metabolism | Neurons - drug effects | Receptors, Cannabinoid - chemistry | Receptors, Cannabinoid - genetics | Nerve Tissue Proteins - antagonists & inhibitors | Muscle, Smooth - innervation | Nerve Tissue Proteins - agonists | Gene Expression Regulation | Myenteric Plexus - drug effects | Cannabidiol - pharmacology | Myenteric Plexus - cytology | Muscle, Smooth - metabolism | Mice, Inbred Strains | Nerve Tissue Proteins - genetics | Colon - metabolism | Cannabinoids - pharmacology | Mice, Knockout | Nerve Tissue Proteins - metabolism | Receptor, Cannabinoid, CB1 - metabolism | Receptor, Cannabinoid, CB2 - metabolism | Cannabinoids - therapeutic use | Animals | Receptor, Cannabinoid, CB1 - genetics | Mice | Colonic Diseases, Functional - metabolism | Muscle, Smooth - cytology | Receptor, Cannabinoid, CB1 - antagonists & inhibitors | In Vitro Techniques | Chronic diseases | Physiological aspects | Medical colleges | G proteins | Membrane proteins | Index Medicus | G protein-coupled receptors | COX-2, cyclooxygenase-2 | CB2, cannabinoid-2 | GI, gastrointestinal | ECS, endocannabinoid system | cDNA, complementary DNA | MAGL, monoacylglycerol lipase | CBD, cannabidiol | CB1, cannabinoid-1 | GE, gastric emptying | LMMP, longitudinal muscle-myenteric plexus layer | GPR55, G protein-coupled receptor 55 | i.c.v., intracerebroventricular administration | i.p., intraperitoneal | FAAH, fatty acid amide hydrolase | EFS, electrical field stimulation | KRS, Krebs–Ringer solution | RT-PCR, reverse transcription polymerase chain reaction | PPARα, peroxisome proliferator-activated receptor-alpha | TRPV1, transient receptor potential vanilloid 1
Journal Article
Journal Article